Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs PepHaūs

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and PepHaūs head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 122 · Grade C

PepHaūs

Visit PepHaūs Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 73 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make PepHaūs a bad call — it's best for readers comparing flexible monthly compounded treatment with a larger prepaid commitment who want named care and pharmacy contacts. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
78
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
82
Track Record
88
77
CoreAge RxBrief Score 94 · 73PepHaūs

Price, coverage & the tracker

CoreAge RxPepHaūs
Brief Score94/100 (A)73/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$169/mo paid monthly

Six months: $912.60 upfront; advertised $152/mo equivalent is rounded.

Full price details

$169/month compounded semaglutide; six-month prepayment $912.60 (advertised $152/month equivalent)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$239/mo paid monthly

Six months: $1,291 upfront; advertised $215/mo equivalent is rounded.

Full price details

$239/month compounded tirzepatide; six-month prepayment $1,291 (advertised $215/month equivalent)

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states and D.C. advertised for weight-loss care; confirm the selected prescription and pharmacy assignment
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

PepHaūs: Monthly plans list $169 for semaglutide and $239 for tirzepatide. The lower $152/$215 equivalents require six-month prepayments of $912.60/$1,291.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.